Jeethu

Nephrology, CMC Vellore, India.

[Department of Nephrology | CMC Vellore 🇮🇳 @CMCNephrology]

🕯️ It is with profound grief that we at CMC Vellore mourn the passing of Prof. K.V. Johny — the Father of Kidney Transplantation in India. 🕯️

A giant has left us.
His legacy is eternal.

🧵 A tribute to a legend: 🙏🏻

In the late 1960s, Prof. Kaivilayil V Johny trained in renal transplantation at Adelaide, Australia. He returned with a mission, and changed Indian Nephrology forever.

On 2nd February 1971, Prof. KV Johny & Prof. Mohan Rao performed India's FIRST successful kidney transplant at CMC Vellore — a defining moment in the history of Indian medicine.

He founded the Department of Nephrology at CMC Vellore in 1971 - the first of its kind, and launched India's first DM Nephrology training programme, seeding a generation of kidney specialists across the nation.

Under his leadership, CMC Vellore became the gold standard for nephrology & renal transplantation in India.

He was not just a clinician — he was a builder, a teacher, and a visionary who trained nephrologists who now lead kidney care across India and the world.

"A visionary who opened the doors of kidney transplantation in India and transformed the future of renal care."

Rest in peace, Prof. Johny. CMC Vellore and Indian Nephrology will forever stand on the shoulders of your life's work. 🙏

@OffCMCVellore @isn_india @IndiaSoTx @ISNEdu @ISNkidneycare @WomenNeph_india @ttsorg @ASNKidney @goKDIGO

[Department of Nephrology | CMC Vellore 🇮🇳 @CMCNephrology]

📢 RCC 2026 | 9th Annual Renal Symposium & 18th Renal Clinical Conference

📍 Christian Medical College, Vellore
🗓️ July 24–25, 2026
🎯Acute Kidney Injury – The Next Generation

Day 1️⃣: Dive deep into AKI with the latest research, expert insights, and hands-on learning.

Day 2️⃣: Trainees present real clinical cases to an expert nephrology panel—learn, share, and grow!

📚Transformative learning and collaboration await. 🔎 Discover what’s next in kidney care.

Stay tuned to @CMCNephrology for all the latest updates on #RCC2026 ✨

#Nephrology #AKI #RCC2026 #CMCVellore #Nephtwitter

@OffCMCVellore

[ERA - European Renal Association @ERAkidney]

❗️Check out the latest breakthroughs in Nephrology from the past year:
💥 CKD: Finerenone and SGLT2 inhibitors are leading the way!
💥 Glomerulonephritis: A wave of innovative therapies for IgA Nephropathy!
💥 Dialysis: Updates on volume management, cannulation techniques, and remote patient monitoring!
💥 Transplantation: Progress in the diagnosis and treatment of AMR!

#ERA25 #BeyondNephrology

[NEJM @NEJM]

Presented at #ERA25:

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: https://t.co/4Gf0LboOCp

@ERAkidney

[ERA - European Renal Association @ERAkidney]

#ERA25 #BeyondNephrology
1/And now one of the most awaited sessions in Late Breaking Clinical Trials 1: Cutting-Edge Clinical Trials in #Nephrology🥁

🚨 THE CONFIDENCE TRIAL: EFFICACY/SAFETY OF COMBINING FINERENONE WITH EMPAGLIFLOZIN IN PEOPLE WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES

👤Rajiv Agarwal
✖️@AgarwalRajivMD

👤 Peter Rossing
✖️@P_Rossing

👤 Hiddo J.L. Heerspink
✖️@HeerspinkHiddo

👤 Johannes F.E. Mann

[CMC Vellore @OffCMCVellore]

Study by CMC in collab with @LSHTM shows high numbers of scrub typhus in the rural communities - potentially life-threatening disease spread by infected larval mites. Study of 32,000 people in rural areas of Tamil Nadu, shows scrub typhus to be a leading cause of hospitalisations for #fever.
If left untreated, severe illness from infection can lead to Acute Respiratory Distress Syndrome (ARDS), shock, meningitis & kidney failure; treated using #antibiotics but currently, no preventive vaccine.
Significant study highlights need to spread awareness & improve diagnostics for timely treatment of affected.
Study supported by @The_MRC and published in @NEJM
Read more: https://t.co/WwI6O1JiUi
#research

[Kidney International @Kidney_Int]

#ApolipoproteinE is enriched in dense deposits and is a marker for #densedepositdisease in #C3glomerulopathy

https://t.co/P2CW9x3uXC

@MayoClinicPath @MayoClinicNeph @CedarsSinaiMed @unicampoficial @lalpathlabs
#OpenAccess #Complement #kidneydisease

[Namrata Krishnan @NamrataKrishna3]

Excited to launch our CRRT online curriculum developed in collaboration with John Sperati @hopkinsneph and NKF @nkf. Especially geared towards renal/critical care fellows, but a valuable and free resource for anyone interested in CRRT. @YaleNephrology @YaleIMed
Link below

[Sanjeev Sethi @SethiRenalPath]

Finally. We figured out the dense deposits in dense deposit disease (DDD).

The answer is Apolipoprotein E.

You can stain for APOE & make the diagnosis of DDD in >80% cases. Without electron 🔬.

DDD was the reason I got into mass spectrometry 17 yrs ago. https://t.co/fQxitNbFYF

[Arvind Canchi (Conjeevaram)🇮🇳 @arvindcanchi]

💥In my practise, I see pts with post-transplant erythrocytosis - hope to use this drug at some point in time in the future!
💥Rusfertide, an injectable peptide mimetic of the master iron regulatory hormone hepcidin, restricts the availability of iron for erythropoiesis.
💥In patients with polycythemia vera, rusfertide treatment was associated with a mean hematocrit of less than 45% during the 28-week dose-finding period, and the percentage of patients with a response during the 12-week randomized withdrawal period was greater with rusfertide than with placebo
https://t.co/VKcNVLIofg

[Jeethu @jjeapen]

Congrats to researchers from @iiscbangalore on a very important and often neglected problem in India...🐍bite.. Hope clinical trials are not far away..

[Kartik Sunagar @venomdetective]

Our paper on the cover of @ScienceTM! What's more, it features my photograph of a cobra from our beautiful @iiscbangalore

This is a collab with Jardine lab at @scrippsresearch, @CSRIatLSTM, et al. Takes us 1 step closer to Universal antivenom for treating snakebite

@LabVenomics

[Jeethu @jjeapen]

E-poster presentations at the @OffCMCVellore Annual Renal Symposium...

[Jeethu @jjeapen]

7th Annual Renal Symposium at @OffCMCVellore #Nephrology on Renal Transplant Infections.

[Gopambuj Singh Rathod @IamGopambuj]

Sharp crisp and excellent session on primary GN by Dr. Selvin S sir from CMC Vellore at #ISNCON23

[CMC Vellore @OffCMCVellore]

46 years after transplant, #Asia’s longest surviving #kidney recipient, dies at 70.
Krishna Ram Sharma, a native of Rajasthan, had undergone the #kidneytransplant at CMC Vellore in the year 1977, when he was in his 20s.
https://t.co/TRVBRpBObo
#milestone #Survivor #india

[NDT @NDTsocial]

📢Selected from our new Supplement on

"Novel diagnostic and therapeutic perspectives for immune-mediated kidney diseases":

The five types of glomerulonephritis classified by pathogenesis, activity and chronicity (GN-AC)

🔓https://t.co/IMFLcXdFZv

[Pediatric Nephrology @Ped_Neph]

Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease & is one of the most frequent genetic causes for kidney failure in children & adolescents. Read this Review of pathological findings & recent genetic advances in NPHP & NPHP-RC.
https://t.co/beEHQd2SzT

[Jeethu @jjeapen]

@WRajaleelan Great going Sush!!

[ASN Kidney News @KidneyNews]

Obesity contributes to a significant portion of CKD, increasing the risk of adverse cardiometabolic outcomes in people with CKD. Recent innovations in obesity treatment bring change to the future for nephrology patients and the field https://t.co/xGqPzamOQT

[Jeethu @jjeapen]

Time to look back..A review of the First ABO incompatible Kidney Transplant without Splenectomy in India...14 years back.. @indianjnephrol @OffCMCVellore
DOI:10.4103/ijn.ijn_295_21